TipRanks

Susan Mahony Insider Profile

4 Followers
Susan Mahony, Director at Axsome Therapeutics, holds 829.00 shares in Axsome Therapeutics (Ticker: AXSM), holds 46.61K shares in Eli Lilly & Co (Ticker: LLY), holds ― shares in Assembly Biosciences (Ticker: ASMB).
tipranks
Susan Mahony

Susan Mahony
Axsome Therapeutics (AXSM)
Director

Ranked #72,700 out of 109,193 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-19.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$55M
99.72%
0.28%
0.00%
0.00%
A breakdown of Susan Mahony's holdings

Insider Roles

Eli Lilly & Co
(LLY)
SVP & Pres., Lilly Oncology
Axsome Therapeutics
(AXSM)
Director
Assembly Biosciences
(ASMB)
Director
Zymeworks
(ZYME)
Director
Roles that Susan Mahony holds in companies

Most Profitable Insider Trade

Stock:
Eli Lilly & Co
(LLY)
Rating:Informative Sell
Date:Jul 29, 2015 - Jul 29, 2016
Return:0.00%
The most profitable trade made by Susan Mahony

Susan Mahony's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Axsome Therapeutics
Jun 10, 2026
Director
Uninformative Buy
194.93K
$154.31K
Eli Lilly & Co
Apr 17, 2018
SVP & Pres., Lilly Oncology
Uninformative Sell
1.81M
$55.22M
Assembly Biosciences
―
Director
―
―
HZNP
Horizon Therapeutics
Oct 06, 2023
―
Uninformative Sell
2.17M
$0.00
Zymeworks
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Susan Mahony's performance on stock

Susan Mahony insider profile FAQ

What is the percentage of profitable transactions made by Susan Mahony?
The percentage of profitable transactions made by Susan Mahony is 0%.
    What is the average return per transaction made by Susan Mahony?
    The average return per transaction made by Susan Mahony is -19.50%.
      What stocks does Susan Mahony hold?
      Susan Mahony holds: AXSM, LLY, ASMB, HZNP, ZYME stocks.
        What was Susan Mahony’s latest transaction?
        Susan Mahony latest transaction was an Uninformative Buy of $194.93K.
          What was Susan Mahony's most profitable transaction?
          Susan Mahony’s most profitable transaction was an Informative Sell of LLY stock on July 29, 2015. The return on the trade was 0.00%.
            What is Susan Mahony's role in Axsome Therapeutics?
            Susan Mahony's role in Axsome Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.